scholarly journals Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer

2019 ◽  
Vol 177 (2) ◽  
pp. 469-475 ◽  
Author(s):  
Y. Andersson ◽  
L. Bergkvist ◽  
J. Frisell ◽  
J. de Boniface
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Sentinel Node ◽  
External Validity ◽  
Target Population ◽  
Trial Data ◽  
National Register ◽  
Validity Analysis ◽  
Versus Trial

scholarly journals American College of Surgeons Oncology Group (ACOSOG)

2006 ◽  
Vol 9 (S1) ◽  
pp. 45-53
Author(s):  
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Sentinel Node ◽  
Axillary Node ◽  
Phase Iii ◽  
List Type ◽  
Oncology Group ◽  
Current Contact ◽  
American College Of Surgeons ◽  
Estrogen Receptor Positive

This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by American College of Surgeons Oncology Group (ACOSOG). Clinical trials include: ACOSOG Z1031: A randomized phase III trial comparing 16–18 weeks of neoadjuvant exemestane (25mg daily), letrozole (2.5mg), or anastrozole (1mg) in postmenopausal women with clinical stages II and III estrogen receptor positive breast cancer.ACOSOG Z0010: A prognostic study of sentinel node and bone marrow micrometastases in women with clinical T1 or T2 N0 M0 breast cancer.ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1–2 N0 M0 breast cancer who have a positive sentinel node.

Sign in / Sign up

Export Citation Format

Share Document